ResMed | RMD - Ebit

金融业

USD

USD 8.78B

现金及等价物

USD 1.66B

USD 551.67M

USD 4.06B

USD 1.35B

USD 847.72M

股息收益率

1.04

USD 505.67M

USD 547.48M

10.6K

EPS每股收益

USD 2.86

股本和储备

USD 6.49B

USD 890.98M

债务利息支出

USD 8.79M

USD 59K

USD 404.17M

USD 30.94B

USD 398.73M

USD 925.74M

USD 505.67M

普通股股本

USD 190.83M

21.21

USD 496.15M

USD 1.4B

销售和管理费用

USD 279.8M

USD 911.88M

贸易债权人

USD 273.3M

应收帐款人

USD 998.84M

	Ebit	更改		日
Ansell	USD 146.5M		29.2M	2025-12
Artivion	USD 4.79M		6.85M	2025-12
AtriCure	USD 526K		1.96M	2026-03
Baxter International	USD 66M		280.2M	2026-03
Cochlear	AUD 261.1M		13.9M	2025-12
Cooper Companies	USD 212.8M		72.4M	2025-12
CSL	USD 2.64B		116M	2025-12
Dexcom	USD 255.3M		67.7M	2026-03
Edwards Lifesciences	USD 514.7M		144.4M	2026-03
Fisher Paykel Healthcare	NZD 298.2M		2.8M	2025-12
Globus Medical	USD 164M		17.31M	2026-03
Haemonetics	USD 67.4M		13.71M	2025-12
Idexx Laboratories	USD 362.59M		46.98M	2026-03
Insulet	USD 122M		24.3M	2026-03
Integra LifeSciences	USD 11.47M		54.54M	2026-03
Intuitive Surgical	USD 859.7M		5.6M	2026-03
Masimo	USD 77.4M		6.5M	2026-03
Medtronic	USD 1.74B		40M	2025-12
Philips	EUR 302M		417M	2026-03
Ramsay Health Care	AUD 541.1M		20.7M	2025-12
ResMed	USD 505.67M		8.07M	2026-03
Sigma Healthcare	AUD 809K		13.76M	2024-12
Sonic Healthcare	AUD 423.94M		80.3M	2024-12
Steris	USD 318.7M		40.7M	2026-03
Teleflex	USD 37.03M		686K	2026-03
Thermo Fisher Scientific	USD 1.91B		389M	2026-03